Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
Younger generations understand nuclear weapons through digital screens rather than personal experience. The future of nuclear risk reduction hinges on the ability to communicate with and engage young people directly; to educate and mobilize them around nuclear issues.
Sign up for our newsletter to get the latest on nuclear and biological threats.
As protein design tools and other biological AI models become more capable of designing novel biological components and systems, the mechanisms to prevent misuse have not kept pace.
The AHS Index is an objective, evidence-based tool that helps countries and organizations set priorities and identify where investments can have the greatest impact. As health threats become more complex and interconnected, maintaining momentum will require sustained investment, stronger partnerships, and continued political commitment.
Multisectoral collaboration is a fundamental requirement for stronger health security.
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
The convergence of artificial intelligence and the life sciences continues to accelerate. The AIxBio Horizon Scan: Spring 2026 shows that while individual advances may seem incremental, their combined trajectory is significant. Progress is outpacing governance frameworks.
The convergence of artificial intelligence and the life sciences is reshaping what’s possible in biology, delivering major advances–ranging from accelerating vaccine discovery to advancing new tools for mitigating the effects of climate change–and new risks. NTI | bio’s AIxBio Horizon Scan looks ahead to where AIxBio capabilities are headed over the coming years.
Some of the world’s largest AI companies—Google DeepMind, OpenAI, and Anthropic—have warned that their models could be misused to cause harm with biology. The India AI Impact Summit is a critical moment for policymakers, scientists, developers, and biosecurity experts to work together on responsible governance that reduces AIxBio risks.
Life science research moves quickly. But not all research carries the same level or type of risk. For funders, the challenge is to identify risks early—without slowing critical research. And now there's a straightforward tool to help address this.
Mirror life operates outside the assumptions that underpin modern biosafety, biosecurity, and medical surveillance, meaning the policy challenge is not only what to regulate — but how to govern a technology that doesn’t yet exist.
The AI-biology convergence offers enormous benefits but also brings about risks as we’ve never seen before. Without action from multiple disciplines, the race for AI development and dominance could become a race to the bottom when it comes to safety and security.
Senior Director, Communications
Director, Communications
Sign up for regular updates on innovative, real-world solutions to existential threats.
